Kim Il Young, Kim Joo Hui, Lee Dong Won, Lee Soo Bong, Rhee Harin, Seong Eun Young, Kwak Ihm Soo, Song Sang Heon
Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Republic of Korea.
Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.
PLoS One. 2017 Feb 14;12(2):e0172137. doi: 10.1371/journal.pone.0172137. eCollection 2017.
Fluid overload is known to be associated with increased mortality in patients with acute kidney injury (AKI) who are critically ill. In this study, we intended to uncover whether the adverse effect of fluid overload on survival could be applied to all of the patients with AKI who received continuous renal replacement therapy (CRRT).
We analyzed 341 patients with AKI who received CRRT in our intensive care units. The presence of fluid overload was defined as a minimum 10% increase in body weight from the baseline. Demographics, comorbid diseases, clinical data, severity of illness [the sequential organ failure assessment (SOFA) score, number of vasopressors, diagnosis of sepsis, use of ventilator] upon ICU admission, fluid overload status, and time elapsed from AKI diagnosis until CRRT initiation were reviewed from the medical charts.
Patients with total fluid overload from 3 days before CRRT initiation to ICU discharge had a significantly lower survival rate after ICU admission, as compared to patients with no fluid overload (P < 0.001). Among patients with sepsis (P < 0.001) or with high SOFA scores (P < 0.001), there was a significant difference in survival of the patients with and without fluid overload. In patients without sepsis or with low SOFA score, there was no significant difference in survival of patients irrespective of fluid overload.
Our study demonstrates that the adverse effect of fluid overload on survival is more evident in patients with sepsis or with more severe illness, and that it might not apply to patients without sepsis or with less severe illness.
已知液体超负荷与危重症急性肾损伤(AKI)患者死亡率增加相关。在本研究中,我们旨在探究液体超负荷对生存率的不良影响是否适用于所有接受连续性肾脏替代治疗(CRRT)的AKI患者。
我们分析了在我们重症监护病房接受CRRT的341例AKI患者。液体超负荷的定义为体重较基线至少增加10%。从病历中回顾了人口统计学资料、合并疾病、临床数据、入住重症监护病房时的疾病严重程度[序贯器官衰竭评估(SOFA)评分、血管升压药使用数量、脓毒症诊断、呼吸机使用情况]、液体超负荷状态以及从AKI诊断到开始CRRT的时间。
与无液体超负荷的患者相比,从开始CRRT前3天到重症监护病房出院期间存在总体液体超负荷的患者入住重症监护病房后的生存率显著更低(P < 0.001)。在脓毒症患者(P < 0.001)或SOFA评分高的患者(P < 0.001)中,有液体超负荷和无液体超负荷的患者生存率存在显著差异。在无脓毒症或SOFA评分低的患者中,无论有无液体超负荷,患者生存率均无显著差异。
我们的研究表明,液体超负荷对生存率的不良影响在脓毒症患者或病情更严重的患者中更为明显,且可能不适用于无脓毒症或病情较轻的患者。